Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome.

Core Evid · 2008 · PMC3012438 · PMID 21221184

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The difference between rimonabant 5 mg and placebo did not reach statistical significance for this outcome.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.